These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26168186)

  • 1. The involvement of vimentin in copper-induced regression of cardiomyocyte hypertrophy.
    Li R; Bourcy K; Wang T; Sun M; Kang YJ
    Metallomics; 2015 Sep; 7(9):1331-7. PubMed ID: 26168186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway.
    Zhou Y; Bourcy K; Kang YJ
    Cardiovasc Res; 2009 Oct; 84(1):54-63. PubMed ID: 19542178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy.
    Zuo X; Xie H; Dong D; Jiang N; Zhu H; Kang YJ
    Cardiovasc Toxicol; 2010 Sep; 10(3):208-15. PubMed ID: 20582486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of copper in regression of cardiac hypertrophy.
    Zheng L; Han P; Liu J; Li R; Yin W; Wang T; Zhang W; Kang YJ
    Pharmacol Ther; 2015 Apr; 148():66-84. PubMed ID: 25476109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size.
    Zhou Y; Jiang Y; Kang YJ
    J Mol Cell Cardiol; 2008 Jul; 45(1):106-17. PubMed ID: 18495151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor recovers suppressed cytochrome c oxidase activity by restoring copper availability in hypertrophic cardiomyocytes.
    Sun M; Zuo X; Li R; Wang T; Kang YJ
    Exp Biol Med (Maywood); 2014 Dec; 239(12):1671-7. PubMed ID: 25107896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes.
    Wang Y; Li ZC; Zhang P; Poon E; Kong CW; Boheler KR; Huang Y; Li RA; Yao X
    Stem Cells; 2015 Oct; 33(10):2973-84. PubMed ID: 26269433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Communication: Copper suppression of vascular endothelial growth factor receptor-2 is involved in the regression of cardiomyocyte hypertrophy.
    Wang T; Li R; Lin C; Sun M; Kang YJ
    Exp Biol Med (Maywood); 2014 Aug; 239(8):948-953. PubMed ID: 24903162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
    Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
    Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Involvement of Cytochrome c Oxidase in Mitochondrial Fusion in Primary Cultures of Neonatal Rat Cardiomyocytes.
    Yin W; Li R; Feng X; James Kang Y
    Cardiovasc Toxicol; 2018 Aug; 18(4):365-373. PubMed ID: 29396798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
    Gorbe A; Giricz Z; Szunyog A; Csont T; Burley DS; Baxter GF; Ferdinandy P
    Basic Res Cardiol; 2010 Sep; 105(5):643-50. PubMed ID: 20349314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca(2+)-sensitive tyrosine kinase Pyk2/CAK beta-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy.
    Hirotani S; Higuchi Y; Nishida K; Nakayama H; Yamaguchi O; Hikoso S; Takeda T; Kashiwase K; Watanabe T; Asahi M; Taniike M; Tsujimoto I; Matsumura Y; Sasaki T; Hori M; Otsu K
    J Mol Cell Cardiol; 2004 Jun; 36(6):799-807. PubMed ID: 15158121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein-2 antagonizes bone morphogenetic protein-4 induced cardiomyocyte hypertrophy and apoptosis.
    Lu J; Sun B; Huo R; Wang YC; Yang D; Xing Y; Xiao XL; Xie X; Dong DL
    J Cell Physiol; 2014 Oct; 229(10):1503-10. PubMed ID: 24648278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase in rat vas deferens and distal colon is not accompanied by inhibition of contraction.
    Patel AI; Hennan JK; Diamond J
    J Pharmacol Exp Ther; 1997 Nov; 283(2):894-900. PubMed ID: 9353411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.
    Zuo X; Dong D; Sun M; Xie H; Kang YJ
    PLoS One; 2013; 8(6):e67549. PubMed ID: 23818984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.